← Back to Clinical Trials
Recruiting NCT06468891

NCT06468891 Analyzing Gait Parameters Among Women With and Without Stress Urinary Incontinence

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06468891
Status Recruiting
Phase
Sponsor Cairo University
Condition Gait
Study Type OBSERVATIONAL
Enrollment 124 participants
Start Date 2024-06-16
Primary Completion 2024-08-20

Eligibility & Interventions

Sex Female only
Min Age 40 Years
Max Age 60 Years
Study Type OBSERVATIONAL
Interventions
Incontinence Symptom Severity IndexForce platformThe STT three-dimensional motion analysis (3DMA) system

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 124 participants in total. It began in 2024-06-16 with a primary completion date of 2024-08-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will contribute to the existing body of knowledge on stress urinary incontinence and its impact on gait. The findings may have implications for the development of targeted interventions and rehabilitation strategies to improve mobility and quality of life in women with stress urinary incontinence

Eligibility Criteria

Inclusion Criteria: * Age between 40-60 years old. * Women with BMI ≥30. * Women are free from any other gynecological disorders or symptoms that may affect the results of the study. * All participants who will be enrolled in the study sign the informed consent form. * All participants will be of multiparas. * All participants will be diagnosed with a mild degree of stress urinary incontinence. Exclusion Criteria: * Pregnancy * Neurological Disorders: such as Parkinson's disease , multiple sclerosis, or any neurological dysfunction that may affect the gait parameters * Musculoskeletal disorders: such as severe osteoarthritis or lower limb amputations * Significant cognitive impairment: or dementia * Previous pelvic surgery as pelvic organ prolapse repair or anti-incontinence procedures. * Other significant medical conditions that could affect gait include severe cardiovascular disease or severe respiratory conditions. * Walking pain.

Contact & Investigator

Central Contact

Alaa M Khedr, BSc

✉ alaa.khedr@deltauniv.edu.eg

📞 00201555001550

Frequently Asked Questions

Who can join the NCT06468891 clinical trial?

This trial is open to female participants only, aged 40 Years or older, up to 60 Years, studying Gait. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06468891 currently recruiting?

Yes, NCT06468891 is actively recruiting participants. Contact the research team at alaa.khedr@deltauniv.edu.eg for enrollment information.

Where is the NCT06468891 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06468891 clinical trial?

NCT06468891 is sponsored by Cairo University. The trial plans to enroll 124 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology